Sign inJoin free

Watch / the global view

Beating concentration risks with a look at Emerging Markets

the global view26 May 202612:17

Beating concentration risks with a look at Emerging Markets

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Key points:

  • Emerging market indices, in Siva’s view, are increasingly concentrated in a handful of AI‑linked tech stocks

  • India is presented as a lower‑correlation, structural growth and diversification opportunity

  • Policy focus, according to Siva, is on renewables and higher‑value exports such as engineering goods and pharmaceuticals

Mugunthan Siva from India Avenue Investment Management outlines why he sees current emerging market exposure as heavily skewed towards a narrow technology theme. He points out that the top five emerging market stocks – including Taiwan Semiconductor, SK Hynix, Samsung, Tencent and Alibaba – now represent about 30% of the asset class, and are highly correlated with the US “AI trade”. In his view, this creates a binary outcome for global equity investors depending on their stance on artificial intelligence.

Siva contrasts this with India, which he states does not share this concentration risk and shows falling correlation with both emerging markets and global equities. India’s IT services names, he notes, have been de‑rated amid concerns about deflation in services, making India, in his opinion, a diversification play away from AI‑driven tech. He highlights structural themes: expansion of data centres, nascent semiconductor capacity, and a policy push towards renewables – solar, hydro and wind – alongside a targeted lift in exports above US$1 trillion.

Siva also cites India’s young demographics and shift up the value chain in engineering goods, pharmaceuticals and specialty chemicals. He describes recent equity performance as “abysmal”, with the Nifty 50 trading near 16.5x forward earnings, below historic averages, which he sees as attractive for long‑term growth investors.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy